It works differently from stimulant medications like Adderall to treat ADHD, says Dr
Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in Atomoxetine, sold under the brand name Strattera, is a medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome
Patients assigned to STRATTERA in the maintenance phase were generally continued on the same dose used to achieve a response in the open label phase
Strattera (Generic Name: atomoxetine) is an alternative to the stimulant ADHD
It may help to Strattera is a non-stimulant medication for ADHD in children and
Strattera and Ritalin are medicines that children and adults can take to manage ADHD
Strattera and Ritalin are prescription medications used to treat attention
In adults, the starting dosage of Strattera for attention deficit hyperactivity disorder (ADHD) is 40 mg once per day
Strattera is approved for the treatment of attention- deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults
STRATTERA is not approved for major depressive disorder
It is usually taken either once a day in the morning, or twice a day in the morning and late afternoon or early evening
However, these prescription medications are not the same
This non-stimulant ADHD medication can also cause high blood pressure
As with other drugs, Strattera can cause side effects, such as nausea Strattera (atomoxetine) is a non-stimulant medication used to treat attention-deficit hyperactivity disorder (ADHD) in children and adults
Share your stories, struggles, and non-medication strategies
Report any new or worsening symptoms to your doctor, such as: anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless
STRATTERA is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years and older, adolescents and adults
Atomoxetine, brand name, Strattera, was approved by the FDA for distribution in November 2002
9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes
In 2002, Strattera ® (atomoxetine [ATX]) was the first non-stimulant medication approved for use in the treatment of ADHD